Click on image to view larger version.

Figure 3 Quantitative analysis of the effects of simvastatin on ¹⁸ F-fluorodeoxyglucose uptake in atherosclerotic plaque inflammation. (A) For quantitative analysis, the maximum standardized uptake values (SUVs) were evaluated in individual plaques and averaged for analysis of the results of the subject-wise SUV at baseline and after 3-month treatment (post-treatment). (B) Changes in plaque SUVs from baseline. Plaque SUVs were significantly reduced by simvastatin, but not by dietary management alone (diet). SUV denotes the changes in the SUV after treatment. Bar = 1 x SD.